David A Carter
Overview
Explore the profile of David A Carter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
637
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li X, Feng H, Zhao S, Carter D
Financ Res Lett
. 2022 Dec;
43:101957.
PMID: 36568951
Banks can potentially reduce the variability of their revenue by diversifying beyond traditional lending activities into noninterest revenue sources. We investigate the effect of the COVID-19 pandemic on the relation...
2.
Klasfauseweh T, Israel M, Ragnarsson L, Cox J, Durek T, Carter D, et al.
Eur J Pharmacol
. 2022 May;
925:175013.
PMID: 35537491
QX-314 is a quaternary permanently charged lidocaine derivative that inhibits voltage-gated sodium channels (Na). As it is membrane impermeable, it is generally considered that QX-314 applied externally is inactive, unless...
3.
Al-Amin M, Sullivan R, Alexander S, Carter D, Bradford D, Burne T
AIMS Neurosci
. 2022 Apr;
9(1):31-56.
PMID: 35434279
Vitamin D deficiency is prevalent in adults and is associated with cognitive impairment. However, the mechanism by which adult vitamin D (AVD) deficiency affects cognitive function remains unclear. We examined...
4.
Young S, Ryan L, Mullins T, Flint M, Steane S, Walton S, et al.
Front Physiol
. 2021 Oct;
12:738594.
PMID: 34621187
Selective SGLT2 inhibition reduces the risk of worsening heart failure and cardiovascular death in patients with existing heart failure, irrespective of diabetic status. We aimed to investigate the effects of...
5.
Wilson D, Bansal P, Carter D, Vetter I, Nicke A, Dutertre S, et al.
Biomedicines
. 2020 May;
8(5).
PMID: 32443665
Conopeptides belonging to the A-superfamily from the venomous molluscs, , are typically α-conotoxins. The α-conotoxins are of interest as therapeutic leads and pharmacological tools due to their selectivity and potency...
6.
Mullins T, Tan W, Carter D, Gallo L
Nephrology (Carlton)
. 2020 Mar;
25(7):575-581.
PMID: 32180312
Aim: The measurement of glomerular filtration rate (GFR) in experimental rodents is pivotal to understanding the progression of kidney disease and benefits of treatment strategies. A non-invasive clearance device has...
7.
Starobova H, Mueller A, Deuis J, Carter D, Vetter I
J Pain
. 2019 Jul;
21(1-2):182-194.
PMID: 31260808
Vincristine, oxaliplatin, and cisplatin are commonly prescribed chemotherapeutic agents for the treatment of many tumors. However, a main side effect is chemotherapy-induced peripheral neuropathy (CIPN), which may lead to changes...
8.
Tan W, Mullins T, Flint M, Walton S, Bielefeldt-Ohmann H, Carter D, et al.
Am J Physiol Regul Integr Comp Physiol
. 2018 Feb;
314(6):R858-R869.
PMID: 29443547
There is an increased incidence of heart failure in individuals with diabetes mellitus (DM). The coexistence of kidney disease in DM exacerbates the cardiovascular prognosis. Researchers have attempted to combine...
9.
Carter D
J Chem Neuroanat
. 2017 Apr;
82:29-38.
PMID: 28419831
The bed nucleus of the stria terminalis (BNST) is a complex integrative centre in the forebrain, composed of multiple sub-nuclei, each with discrete populations of neurons. Progress in understanding BNST...
10.
Li C, Galgano M, Carter D
Cureus
. 2016 Sep;
8(8):e740.
PMID: 27672531
The most frequently encountered complication of dorsal column stimulators is lead migration. The vast majority of these events are seen in the first few weeks to months. Late paddle lead...